Related references
Note: Only part of the references are listed.Safety and Efficacy of 48 and 96 Weeks of Alendronate in Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection and Low Bone Mineral Density for Age
Jane C. Lindsey et al.
CLINICAL INFECTIOUS DISEASES (2021)
Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age
Denise L. Jacobson et al.
CLINICAL INFECTIOUS DISEASES (2020)
Intravenous bisphosphonate therapy in children with spinal muscular atrophy
N. Nasomyont et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children
Rocio Galindo-Zavala et al.
PEDIATRIC RHEUMATOLOGY (2020)
Bone health impairment in patients with cerebral palsy
Jose Miguel Martinez de Zabarte Fernandez et al.
ARCHIVES OF OSTEOPOROSIS (2020)
The mortality burden of non-trauma fracture for adults with cerebral palsy
Daniel G. Whitney et al.
BONE REPORTS (2020)
Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review
Nat Nasomyont et al.
BONE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Pharmacology of bisphosphonates
Serge Cremers et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Annual Injection of Zoledronic Acid Improves Bone Status in Children with Cerebral Palsy and Rett Syndrome
Arnaud Wiedemann et al.
CALCIFIED TISSUE INTERNATIONAL (2019)
The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial
Madeleine Rooney et al.
ECLINICALMEDICINE (2019)
Consensus guidelines on the use of bisphosphonate therapy in children and adolescents
Peter J. Simm et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2018)
Effects of zoledronic acid on children and young adults with low bone mineral density
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility
Anne-Sophie Lambert et al.
PLOS ONE (2017)
Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update
Sezgi Ozel et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2016)
Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy
Julieanne P. Sees et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
The Effect of 6 Versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
Dennis M. Black et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis
Min Jeong Kim et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2015)
Fractures in children with cerebral palsy: a total population study
Ulrika Uddenfeldt Wort et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2013)
A systematic review of interventions for children with cerebral palsy: state of the evidence
Iona Novak et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2013)
Intravenous Zoledronic Acid Given Every 6 Months in Childhood Osteoporosis
Hooi Leng Ooi et al.
HORMONE RESEARCH IN PAEDIATRICS (2013)
Prevention of Postoperative Osteopenia Using IV Pamidronate
Bryon D. Hobby et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2013)
Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate
Maria Luisa Bianchi et al.
LANCET RESPIRATORY MEDICINE (2013)
Oral risedronate sodium improves bone mineral density in non-ambulatory patients: A randomized, double-blind, placebo controlled trial
Valeria Cohran et al.
JOURNAL OF PEDIATRIC REHABILITATION MEDICINE (2013)
Osteopenia in children with cerebral palsy can be treated with oral alendronate
Muhammet Sukru Paksu et al.
CHILDS NERVOUS SYSTEM (2012)
Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: a systematic review
Darcy Fehlings et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2012)
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
Dennis M. Black et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Osteopenia in children with cerebral palsy can be treated with oral alendronate
Muhammet Sukru Paksu et al.
CHILDS NERVOUS SYSTEM (2012)
Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis
Peter J. Simm et al.
BONE (2011)
Bone mineral disease in children after renal transplantation in steroid-free and steroid-treated patients - a prospective study
Ryszard Grenda et al.
PEDIATRIC TRANSPLANTATION (2011)
Decreased fracture incidence after 1 year of pamidronate treatment in children with spastic quadriplegic cerebral palsy
Steven J. Bachrach et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)
The Relationship Between Fractures and DXA Measures of BMD in the Distal Femur of Children and Adolescents With Cerebral Palsy or Muscular Dystrophy
Richard C. Henderson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease
Anne Marie Sbrocchi et al.
PEDIATRICS INTERNATIONAL (2010)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury
Rene Przkora et al.
BONE (2007)
Fractures in patients with cerebral palsy
Ana Presedo et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2007)
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial
Dennis M. Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Fractures in children with cerebral palsy
Arabella I. Leet et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2006)
Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy
Steven J. Bachrach et al.
JOURNAL OF CLINICAL DENSITOMETRY (2006)
Single-dose pharmacokinetics and tolerability of alendronate 35-and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I
LM Ward et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment
S Rudge et al.
RHEUMATOLOGY (2005)
The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study
GL Klein et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Alendronate for the treatment of osteopenia in anorexia nervosa: A randomized, double-blind, placebo-controlled trial
NH Golden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Bone densitometry in pediatric patients treated with pamidronate
LE Grissom et al.
PEDIATRIC RADIOLOGY (2005)
Pamidronate treatment of pediatric fracture patients on chronic steroid therapy
PD Acott et al.
PEDIATRIC NEPHROLOGY (2005)
Treatment of osteopenia and osteoporosis in renal transplant children and adolescents
AA El-Husseini et al.
PEDIATRIC TRANSPLANTATION (2004)
Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: A randomized, placebo-controlled clinical trial
RC Henderson et al.
JOURNAL OF PEDIATRICS (2002)
Share Paper
